Back to Publications
November, 2023
BlueClinical is a founding member of the new pan-European CRO Astrum.
BlueClinical is a founding member of the new pan-European CRO Astrum.
For more information about the new range of available services, visit the new Company's website at www.astrumcro.com.
BlueClinical is a founding member of the new pan-European CRO Astrum, the result of a merger with three other European Companies with complementary skills (Bioclever, from Spain; Popsicube, from France; and Pharmalog, from Germany), and with investment from Henko Partners.
Other Publication
BlueClinical recognized by Agência Nacional de Inovação (ANI)
BlueClinical recognized by Agência Nacional de Inovação (ANI) as an idoneous entity for conducting R&D activities in the field of translational research
BlueClinical @ Swiss Biotech Day 2023
BlueClinical will be present at Swiss Biotech Day 2023. It will be held on April 24-25, 2023 in Basel, Switzerland. Contact us to schedule a meeting at: bd@blueclinical.pt
